SPC297
Kóbísistat eða lyfjafræðilega viðeigandi salt eða lausnarsamband þess, darúnavír eða lyfjafræðilega viðeigandi salt eða lausnarsamband þess, einkum darúnavír etanólat og emtrícítabín eða lyfjafræðilega viðeigandi salt eða lausnarsamband þess
Status:
VeittApplication date:
4.6.2020Application published:
15.6.2020Grant published:
15.3.2021
Max expiry date:
24.9.2032Medicine name:
SymtuzaMedicine for children:
No
Timeline
Today
4.6.2020Application
15.6.2020Publication
15.3.2021Registration
24.9.2032Expires
Marketing license
IS authorization number:
EU/1/17/1225/001Date:
5.10.2017
Foreign authorization number:
EU/1/17/1225Date:
21.9.2017
Owner
Name:
Gilead Sciences, Inc.Address:
333 Lakeside Drive, Foster City, CA 94404 US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP3150586